Severity of self-reported symptoms and psychological burden 6-months after hospital admission for COVID-19: a prospective cohort study.


Journal

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
ISSN: 1878-3511
Titre abrégé: Int J Infect Dis
Pays: Canada
ID NLM: 9610933

Informations de publication

Date de publication:
Nov 2021
Historique:
received: 28 04 2021
revised: 05 08 2021
accepted: 06 09 2021
pubmed: 14 9 2021
medline: 15 12 2021
entrez: 13 9 2021
Statut: ppublish

Résumé

Few studies have reported clinical COVID-19 sequelae six months (M6) after hospital discharge, but none has studied symptom severity. Prevalence and severity of 7 symptoms were estimated until M6 using the self-administered influenza severity scale in COVID-19 hospitalized patients enrolled in the French COVID cohort. Factors associated with severity were assessed by logistic regression. Anxiety, depression and health-related quality of life (HRQL) were also assessed. At M6, among the 324 patients (median age 61 years, 63% men, 19% admitted to intensive care during the acute phase), 187/324 (58%) reported at least one symptom, mostly fatigue (47%) and myalgia (23%). Symptom severity was scored, at most, mild in 125 (67%), moderate in 44 (23%) and severe in 18 (10%). Female gender was the sole factor associated with moderate/severe symptom reporting (OR = 1.98, 95%CI=1.13-3.47). Among the 225 patients with psychological assessment, 24 (11%) had anxiety, 18 (8%) depressive symptoms, and their physical HRQL was significantly poorer than the general population (p=0.0005). Even if 58% of patients reported ≥1 symptom at M6, less than 7% rated any symptom as severe. Assessing symptoms severity could be helpful to identify patients requiring appropriate medical care. Women may require special attention.

Identifiants

pubmed: 34517049
pii: S1201-9712(21)00724-4
doi: 10.1016/j.ijid.2021.09.011
pmc: PMC8432979
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

247-253

Informations de copyright

Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Philippine Eloy (P)

AP-HP, Hôpital Bichat, Département Epidémiologie Biostatistiques et Recherche Clinique, F-75018 Paris, France; INSERM, Centre d'Investigations cliniques-Epidémiologie Clinique 1425, Hôpital Bichat, F-75018 Paris, France. Electronic address: philippine.eloy@aphp.fr.

Coralie Tardivon (C)

AP-HP, Hôpital Bichat, Département Epidémiologie Biostatistiques et Recherche Clinique, F-75018 Paris, France; INSERM, Centre d'Investigations cliniques-Epidémiologie Clinique 1425, Hôpital Bichat, F-75018 Paris, France.

Guillaume Martin-Blondel (G)

Service des Maladies Infectieuses et Tropicales, CHU de Toulouse.

Margaux Isnard (M)

Service de Maladies Infectieuses et Médecine Interne, CH Métropole Savoie.

Paul LE Turnier (PL)

Department of Infectious Diseases, Hotel-Dieu Hospital - INSERM CIC 1413, Nantes University Hospital, Nantes, France.

Marion LE Marechal (ML)

CHU Grenoble Rhône Alpes, Service de Maladies Infectieuses et Médecine Tropicale, F-38000 Grenoble, France.

André Cabié (A)

Inserm CIC 1424, Université des Antilles EA 7524, Service de maladies infectieuses et tropicales, CHU de Martinique, F-97200 Fort-de-France, France.

Odile Launay (O)

Inserm CIC 1417, Faculté de Médecine Paris Descartes, Univ Paris, AP-HP, Hôpital Cochin, Paris, France.

Pierre Tattevin (P)

Infectious Diseases and Intensive Care Unit, Pontchaillou University Hospital, University Rennes-1, Rennes, France.

Eric Senneville (E)

Infectious Diseases Department, Gustave Dron Hospital, 59200 Tourcoing, France.

Séverine Ansart (S)

Tropical and Infection Diseases Unit, CHRU de Brest, F-29200 Brest, France.

François Goehringer (F)

Service de Maladies Infectieuses et Tropicales, Centre Régional Universitaire de Nancy, Hôpitaux de Brabois, Rue du Morvan, 54511 Vandoeuvre Lés Nancy, France.

Catherine Chirouze (C)

CHU Besançon, Service de Maladie Infectieuses et Tropicales, F-25000, Besançon, France.

Laurane Bousson (L)

INSERM, Centre d'Investigations cliniques-Epidémiologie Clinique 1425, Hôpital Bichat, F-75018 Paris, France.

Cédric Laouénan (C)

AP-HP, Hôpital Bichat, Département Epidémiologie Biostatistiques et Recherche Clinique, F-75018 Paris, France; INSERM, Centre d'Investigations cliniques-Epidémiologie Clinique 1425, Hôpital Bichat, F-75018 Paris, France; Université de Paris, INSERM, IAME UMR 1137, Paris, France.

Manuel Etienne (M)

CHU Rouen, Service des Maladies Infectieuses et Tropicales, F-76000 Rouen, France.

Duc Nguyen (D)

Department of Infectious and Tropical Diseases, CHU de Bordeaux, Bordeaux, France.

Jade Ghosn (J)

Université de Paris, INSERM, IAME UMR 1137, Paris, France; AP-HP, Hôpital Bichat, Infectious and Tropical Diseases Department, Paris, France.

Xavier Duval (X)

Université de Paris, INSERM, IAME UMR 1137, Paris, France; AP-HP, Hôpital Bichat, Centre d'Investigation Clinique, Inserm CIC 1425, F-75018 Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH